Company: GLRE
Filing Date: 2025-08-04
Form Type: 10-Q
Source: 0001385613-25-000079
Chunk: 56

Company: GREENLIGHT CAPITAL RE, LTD.
Filing Date: 2025-08-04
Form: 10-Q
Item: Part I, Item 1
Chunk 56
---
,126 Corporate and other expenses— (1,400)(7,681)(9,081)Income from investment in Solasglas22,578 22,578 Foreign exchange gains (losses)(2,581)(2,581)Interest expense(2,809)(2,809)Income (loss) before income taxes$34,743 $1,252 $(44)$35,951 Additional information:Net loss and LAE incurred:  Attritional losses$(140,553)$(28,403)$(11,952)$(180,908)  Large event losses(8,017)— — (8,017)  CAT event losses(10,000)— (7,722)(17,722)  Prior year favorable (adverse) loss development(1,533)1,642 (4,821)(4,712)Total net loss and LAE incurred$(160,103)$(26,761)$(24,495)$(211,359)Total allocated assets (1)$402,186 $140,253 $1,357,509 $1,899,948 

(1) The Company does not allocate assets to reporting segments, with the exception of restricted cash used to collateralized certain reinsurance transactions, including FAL, and  Innovations-related private investments. 

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References to “we,” “us,” “our,” “our company,” or “the Company” refer to Greenlight Capital Re, Ltd. (“GLRE”) and its wholly-owned subsidiaries unless the context dictates otherwise. 

The following discussion should be read in conjunction with the audited consolidated financial statements and accompanying notes, which appear in our 2024 Form 10-K.

The following is management’s discussion and analysis (“MD&A”) of our results of operations for the three and six months ended June 30, 2025 and 2024 and the Company’s financial condition at June 30, 2025 and December 31, 2024.

24

All amounts are reported in U.S. dollars, unless otherwise noted. Tabular dollars are presented in thousands, with the exception of per share amounts or as otherwise noted.  

Page

Overview26Business Overview26Outlook and Trends26Key Financial Measures and Non-GAAP Measures27Consolidated Results